- Home
- AC vs ORIC Comparison
AC vs ORIC Comparison
Compare AC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AC
- ORIC
- Stock Information
- Founded
- AC 1976
- ORIC 2014
- Country
- AC United States
- ORIC United States
- Employees
- AC N/A
- ORIC N/A
- Industry
- AC Investment Bankers/Brokers/Service
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- AC Finance
- ORIC Health Care
- Exchange
- AC Nasdaq
- ORIC Nasdaq
- Market Cap
- AC 765.5M
- ORIC 653.9M
- IPO Year
- AC N/A
- ORIC 2020
- Fundamental
- Price
- AC $36.60
- ORIC $9.95
- Analyst Decision
- AC
- ORIC Strong Buy
- Analyst Count
- AC 0
- ORIC 9
- Target Price
- AC N/A
- ORIC $18.75
- AVG Volume (30 Days)
- AC 11.2K
- ORIC 471.5K
- Earning Date
- AC 11-15-2024
- ORIC 11-19-2024
- Dividend Yield
- AC 0.26%
- ORIC N/A
- EPS Growth
- AC 85.41
- ORIC N/A
- EPS
- AC 1.54
- ORIC N/A
- Revenue
- AC $13,442,000.00
- ORIC N/A
- Revenue This Year
- AC N/A
- ORIC N/A
- Revenue Next Year
- AC N/A
- ORIC N/A
- P/E Ratio
- AC $23.72
- ORIC N/A
- Revenue Growth
- AC N/A
- ORIC N/A
- 52 Week Low
- AC $28.58
- ORIC $5.85
- 52 Week High
- AC $43.85
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- AC 51.86
- ORIC 56.86
- Support Level
- AC $34.16
- ORIC $8.71
- Resistance Level
- AC $36.46
- ORIC $10.55
- Average True Range (ATR)
- AC 1.23
- ORIC 0.75
- MACD
- AC -0.26
- ORIC 0.17
- Stochastic Oscillator
- AC 24.09
- ORIC 75.10
About AC Associated Capital Group Inc.
Associated Capital Group Inc is a diversified global financial services company. It operates in the business of alternative investment management, institutional research services, and cash and other assets through subsidiaries. The activities of its subsidiaries comprise publishing daily research notes and full reports using private market value with a catalyst methodology and also products and customized solutions utilizing private market value with catalyst method of investing.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.